Matching-Adjusted Indirect Comparison of Current Treatments for NMOSD and Evaluation of Long-Term Effectiveness

被引:0
|
作者
Paul, Friedemann [1 ]
Aktas, Orhan [2 ]
Pedersen, Mikkel [3 ]
Vilela, Francisco Sorio [4 ]
Patterson, Kristina [4 ]
Rampal, Nishi [4 ]
Cimbora, Daniel [4 ]
Cree, Bruce [5 ]
机构
[1] Max Delbruck Ctr Mol Med, Berlin, Germany
[2] Heinrich Heine Univ Dusseldorf, Dusseldorf, Germany
[3] Incentive, Holte, Denmark
[4] Horizon Therapeut, Deerfield, IL USA
[5] UCSF, Weill Inst Neurosci, San Francisco, CA USA
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P011/1038
引用
收藏
页码:144 / 145
页数:2
相关论文
共 50 条
  • [41] PERFORMANCE COMPARISON OF UNANCHORED MATCHING-ADJUSTED INDIRECT COMPARISON AND NAIVE TREATMENT INDIRECT COMPARISON ON SURVIVAL OUTCOMES: A SIMULATION STUDY
    Liu, Y.
    Liu, J.
    He, X.
    Wu, J.
    VALUE IN HEALTH, 2022, 25 (12) : S366 - S366
  • [42] Comparative Effectiveness of Bimekizumab and Ustekinumab in Patients with Psoriatic Arthritis at 52 Weeks Assessed Using a Matching-Adjusted Indirect Comparison
    Mease, Philip J.
    Warren, Richard B.
    Nash, Peter
    Grouin, Jean-Marie
    Lyris, Nikos
    Taieb, Vanessa
    Eells, Jason
    McInnes, Iain B.
    RHEUMATOLOGY AND THERAPY, 2024, 11 (05) : 1413 - 1423
  • [43] Comparative Effectiveness of Bimekizumab and Guselkumab in Patients with Psoriatic Arthritis at 52 Weeks Assessed Using a Matching-Adjusted Indirect Comparison
    Warren, Richard B.
    Mcinnes, Iain B.
    Nash, Peter
    Grouin, Jean-Marie
    Lyris, Nikos
    Willems, Damon
    Taieb, Vanessa
    Eells, Jason
    Mease, Philip J.
    RHEUMATOLOGY AND THERAPY, 2024, 11 (03) : 829 - 839
  • [44] Comparative effectiveness of secukinumab and etanercept in biologic-naive patients with psoriatic arthritis assessed by matching-adjusted indirect comparison
    Mease, Philip
    Choy, Ernest
    Nash, Peter
    Kalyvas, Chrysostomos
    Hunger, Matthias
    Pricop, Luminita
    Gandhi, Kunal K.
    Jugl, Steffen M.
    Thom, Howard
    EUROPEAN JOURNAL OF RHEUMATOLOGY, 2019, 6 (03) : 113 - +
  • [45] Secukinumab Versus Adalimumab for Psoriatic Arthritis: Comparative Effectiveness up to 48 Weeks Using a Matching-Adjusted Indirect Comparison
    Nash, Peter
    McInnes, Iain B.
    Mease, Philip J.
    Thom, Howard
    Hunger, Matthias
    Karabis, Andreas
    Gandhi, Kunal
    Mpofu, Shephard
    Jugl, Steffen M.
    RHEUMATOLOGY AND THERAPY, 2018, 5 (01) : 99 - 122
  • [46] Comparative Effectiveness of Bimekizumab and Risankizumab in Patients with Psoriatic Arthritis at 52 Weeks Assessed Using a Matching-Adjusted Indirect Comparison
    Mease, Philip J.
    Warren, Richard B.
    Nash, Peter
    Grouin, Jean-Marie
    Lyris, Nikos
    Willems, Damon
    Taieb, Vanessa
    Eells, Jason
    Mcinnes, Iain B.
    RHEUMATOLOGY AND THERAPY, 2024, 11 (05) : 1403 - 1412
  • [47] Secukinumab Versus Adalimumab for Psoriatic Arthritis: Comparative Effectiveness up to 48 Weeks Using a Matching-Adjusted Indirect Comparison
    Peter Nash
    Iain B. McInnes
    Philip J. Mease
    Howard Thom
    Matthias Hunger
    Andreas Karabis
    Kunal Gandhi
    Shephard Mpofu
    Steffen M. Jugl
    Rheumatology and Therapy, 2018, 5 : 99 - 122
  • [48] ASSESSING POPULATION-ADJUSTED INDIRECT COMPARISON METHODS (MATCHING-ADJUSTED INDIRECT COMPARISON AND SIMULATED TREATMENT COMPARISON) USING MONTE-CARLO SIMULATIONS
    Parks, D.
    Ferrante, S. A.
    VALUE IN HEALTH, 2019, 22 : S321 - S321
  • [49] Matching-adjusted indirect treatment comparison of ozanimod versus teriflunomide for relapsing multiple sclerosis
    Cohan, Stanley
    Tencer, Tom
    Arndorfer, Stella
    Zhu, Xuelian
    Zivkovic, Marko
    Kumar, Jinender
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 52
  • [50] Matching-Adjusted Indirect Comparison Studies in Oncology: A Scoping Review Focused on Reporting Quality
    Farinasso, Cecilia Menezes
    Ferreira, Vinicius Lins
    Medeiros, Flavia Cordeiro
    da Rocha, Aline Pereira
    Parreira, Patricia do Carmo Silva
    Oliveira, Layssa Andrade
    Marra, Lays Pires
    Lucchetta, Rosa Camila
    de Oliveira Jr, Haliton Alves
    VALUE IN HEALTH REGIONAL ISSUES, 2025, 47